Abstract
Testicular cancer is the most common malignancy encountered among males aged 20–40 years and accounts for 1–1.5 % of cancers in men and 5 % of all urological tumours [1]. There is a significant geographic variation in the incidence of this malignancy especially germ cell tumours (GCTs): Scandinavian countries, Germany and Switzerland record the highest incidence, while the lowest is reported in African and Asian countries [1]. The estimated incidence of testicular tumours in Western countries is 3–10 new cases per 100,000 males per year [2]. In the last 30–40 years, a trend towards an increased testicular cancer incidence has been documented in the majority of industrialized countries, especially in Northern European countries, North America and Oceania [3–6]. It has been suggested that the birth cohort hypothesis plays a major role towards this trend, as Nordic men born around 1943 and 1968 showed lower incidences than men born just before or just after these dates [4, 7, 8].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Horner MJ, Ries LA, et al. SEER cancer statistics review, 1975–2006. Bethesda: National Cancer Institute; 2009.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.
Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol. 2003;170:5–11.
Jacobsen R, Moller H, Thoresen SO, Pukkala E, Kjaer SK, Johansen C. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl. 2006;29:199–204.
Shah MN, Devesa SS, Zhu K, McGlynn KA. Trends in testicular germ cell tumours by ethnic group in the United States. Int J Androl. 2007;30:206–13; discussion 13–4.
Baade P, Carriere P, Fritschi L. Trends in testicular germ cell cancer incidence in Australia. Cancer Causes Control. 2008;19:1043–9.
Ekbom A, Akre O. Increasing incidence of testicular cancer – birth cohort effects. APMIS. 1998;106(1):225–9; discussion 229–31.
Bergström R, Adami HO, Möhner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst. 1996;88(11):727–33.
McGlynn KA, Devesa SS, Graubard BI, Castle PE. Increasing incidence of testicular germ cell tumours among black men in the United States. J Clin Oncol. 2005;23(24):5757–61.
Stephenson AJ, Gilligan TD. Neoplasms of the testis. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. Chapter 31, vol. 1. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 837–70.
Mostofi FK. Proceedings: testicular tumours. Epidemiologic, etiologic, and pathologic features. Cancer. 1973;32(5):1186–201.
Swerdlow AJ, Higgins CD, Pike MC. Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ. 1997;314:1507–11.
Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumours. World J Urol. 2004;22:2–14.
Akre O, Pettersson A, Richiardi L. Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta-analysis. Int J Cancer. 2009;124(3):687–9.
Berthelsen JG, Skakkebaek NE, von der Maase H, Sørensen BL, Mogensen P. Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. Br Med J (Clin Res Ed). 1982;285(6356):1683–6.
Skakkebaek NE, Berthelsen JG, Müller J. Carcinoma-in-situ of the undescended testis. Urol Clin North Am. 1982;9(3):377–85.
Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer. 1999;83(6):815–22.
Montironi R. Intratubular germ cell neoplasia of the testis: testicular intraepithelial neoplasia. Eur Urol. 2002;41(6):651–4.
Theodore C, Terrier-Lacombe MJ, Laplanche A, Benoit G, Fizazi K, Stamerra O, Wibault P. Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy. Br J Cancer. 2004;90(1):55–9.
Fosså SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst. 2005;97(14):1056–66.
Mai PL, Chen BE, Tucker K, et al. Younger age at diagnosis for familial malignant testicular germ cell tumour. Fam Cancer. 2009;8(4):451–6.
Hemminki K, Chen B. Familial risks in testicular cancer as aetiological clues. Int J Androl. 2006;29:205–10.
Hemminki K, Li X. Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer. 2004;90:1765–70.
Dieckmann KP, Pichlmeier U. The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature. Cancer. 1997;80:1954–60.
Heimdal K, Olsson H, Tretli S, Fossa SD, Borresen AL, Bishop DT. A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer. 1997;75:1084–7.
Ilson DH, Bosl GJ, Motzer R, Dmitrovsky E, Chaganti RS. Genetic analysis of germ cell tumours: current progress and future prospects. Hematol Oncol Clin North Am. 1991;5(6):1271–83.
Bosl GJ, Dmitrovsky E, Reuter VE, Samaniego F, Rodriguez E, Geller NL, Chaganti RS. Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumours. J Natl Cancer Inst. 1989;81(24):1874–8.
Rosenberg C, Van Gurp RJ, Geelen E, Oosterhuis JW, Looijenga LH. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene. 2000;19(51):5858–62.
Goedert JJ, Purdue MP, McNeel TS, et al. Risk of germ cell tumours among men with HIV/acquired immunodeficiency syndrome. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1266–9.
Pirgon O, Dündar BN. Vanishing testes: a literature review. J Clin Res Pediatr Endocrinol. 2012;4(3):116–20.
Rayson D, Burch PA, Richardson RL. Sarcoidosis and testicular carcinoma. Cancer. 1998;83(2):337–43.
Eble JN. Spermatocytic seminoma. Hum Pathol. 1994;25(10):1035–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Al-Hooti, Q.M., Al-Mamari, S.A. (2015). Epidemiology and Aetiology of Testicular Cancers. In: Al-Mamari, S., Al-Busaidy, S. (eds) Urological Cancer Management. Springer, Cham. https://doi.org/10.1007/978-3-319-16301-7_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-16301-7_17
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16300-0
Online ISBN: 978-3-319-16301-7
eBook Packages: MedicineMedicine (R0)